Paper2328201
Synergism between 5-fluorouracil and N-methylformamide in HT29 human colon cancer line.
Laudonio N and 4 others. Br J Cancer, 1990. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. Synergism between 5-fluorouracil and N-methylformamide in HT29 human colon cancer line. Papers, record 2328201. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2328201
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenocarcinoma | Major topic |
| Antineoplastic Combined Chemotherapy Protocols | Major topic |
| Colonic Neoplasms | Major topic |
| Animals | |
| Cell Line | |
| DNA Damage | |
| DNA, Neoplasm | |
| Drug Synergism | |
| Fluorouracil | |
| Formamides | |
| Humans | |
| Male | |
| Mice | |
| Mice, Nude | |
| Neoplasm Transplantation | |
| Tumor Cells, Cultured |
Source PubMed
References15
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1247994 | Effect of adriamycin on the cell cycle traverse and kinetics of cultured human lymphoblasts. | Cancer Res | 1976 | https://conductscience.org/library/papers/1247994 | PubMed |
| 2 | 3167866 | Modulation of the cytotoxic effect of 5-fluorouracil by N-methylformamide on a human colon carcinoma cell line. | Cancer Res | 1988 | https://conductscience.org/library/papers/3167866 | PubMed |
| 3 | 6430549 | Interaction between 5-fluorouracil and DNA of human colon adenocarcinoma. | Cancer Res | 1984 | https://conductscience.org/library/papers/6430549 | PubMed |
| 4 | 6488157 | Enhancement by N-methylformamide of the effect of ionizing radiation on a human colon tumor xenografted in nude mice. | Cancer Res | 1984 | https://conductscience.org/library/papers/6488157 | PubMed |
| 5 | 4018116 | N-Methylformamide (NSC 3051): a potential candidate for combination chemotherapy. | Eur J Cancer Clin Oncol | 1985 | https://conductscience.org/library/papers/4018116 | PubMed |
| 6 | 4055454 | Enhancement of the responses of human colon adenocarcinoma cells to X-irradiation and cis-platinum by N-methylformamide (NMF). | Int J Radiat Oncol Biol Phys | 1985 | https://conductscience.org/library/papers/4055454 | PubMed |
| 7 | 3948299 | The antitumour effect and toxicity of cis-platinum and N-methylformamide in combination. | Cancer Chemother Pharmacol | 1986 | https://conductscience.org/library/papers/3948299 | PubMed |
| 8 | 2942236 | DNA lesions in human neoplastic cells and cytotoxicity of 5-fluoropyrimidines. | Cancer Res | 1986 | https://conductscience.org/library/papers/2942236 | PubMed |
| 9 | 2428792 | Enhanced X ray sensitivity of human colon tumor cells by combination of N-methylformamide with chemotherapeutic agents. | Int J Radiat Oncol Biol Phys | 1986 | https://conductscience.org/library/papers/2428792 | PubMed |
| 10 | 3547773 | Alkylformamides as inducers of tumour cell differentiation--a mini-review. | Toxicology | 1987 | https://conductscience.org/library/papers/3547773 | PubMed |
| 11 | 2954951 | Deoxyribonucleoside triphosphate imbalance. 5-Fluorodeoxyuridine-induced DNA double strand breaks in mouse FM3A cells and the mechanism of cell death. | J Biol Chem | 1987 | https://conductscience.org/library/papers/2954951 | PubMed |
| 12 | 3277636 | Can anticancer therapy be improved by sequential use of cytotoxic and cytostatic (differentiating or immunomodulating) agents to suppress tumor cell phenotypic diversification? | Biochem Pharmacol | 1988 | https://conductscience.org/library/papers/3277636 | PubMed |
| 13 | 3349474 | Accumulation of DNA strand breaks in cells exposed to methotrexate or N10-propargyl-5,8-dideazafolic acid. | Cancer Res | 1988 | https://conductscience.org/library/papers/3349474 | PubMed |
| 14 | 3370637 | Effects of N-methylformamide on the growth, cell cycle, and glutathione status of murine TLX5 lymphoma cells. | Cancer Res | 1988 | https://conductscience.org/library/papers/3370637 | PubMed |
| 15 | 6212116 | 5-Fluorouracil incorporation in DNA of human breast carcinoma cells. | Cancer Res | 1982 | https://conductscience.org/library/papers/6212116 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 17932567 | Telomere damage induced by the G-quadruplex ligand RHPS4 has an antitumor effect. | J Clin Invest | 2007 | https://conductscience.org/library/papers/17932567 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2328201
GET https://conductscience.org/api/papers/v1/2328201/authors